Doxorubicin induces aggregation of small negatively charged liposomes

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 43, Issue 1, 1997, Pages 9-17

  Fonseca, M J ^a   Van Winden, E C A ^a   Crommelin, D J A ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Acidic phospholipid; Bilayer composition; Doxorubicin; Liposomes; Phase transition temperature; Vesicle aggregation; Vesicle size

Indexed keywords

CHOLESTEROL; DIMYRISTOYLPHOSPHATIDYLCHOLINE; DIPALMITOYLPHOSPHATIDYLCHOLINE; DIPALMITOYLPHOSPHATIDYLGLYCEROL; DOXORUBICIN; LIPOSOME; PHOSPHATIDYLSERINE;

ARTICLE; DRUG ACCUMULATION; DRUG FORMULATION; DRUG UPTAKE; LIPID BILAYER; MEMBRANE POTENTIAL; MEMBRANE VESICLE; TEMPERATURE SENSITIVITY;

EID: 0031398529     PISSN: 09396411     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0939-6411(96)00018-5     Document Type: Article

References (22)

1. Booser DJ, Hortobagyi GN. Anthracycline antibiotics in cancer therapy: Focus on drug resistance. Drugs 1994;47:223-258.
2. Senior J, Crawley JCW, Gregoriadis G. Tissue distribution of liposomes exhibiting long half-lives in the circulation after in vivo injection. Biochim. Biophys. Acta 1985;839:1-8.
3. Huang KJ. Liposome pharmacokinetics. In: Ostro MJ, editor. Liposomes from biophysics to therapeutics. New York: Marcel Dekker, 1987:109-156.
4. Gabizon A, Papahadjopoulos D. Liposome formulations with prolonged circulation time in blood and enhanced uptake by tumors. Proc. Natl. Acad. Sci. USA 1988;85:6949-6953.
5. Storm G, Nässander UK, Vingerhoeds MH, Steerenberg PA, Crommelin DJA. Antibody-targeted liposomes to deliver doxorubicin to ovarian cancer cells. J. Lip. Res. 1994;4:641-666.
6. Balazsovits JAE, Mayer LD, Bally MDB, Cullis PR, McDonell M, Gingsberg RS, Falk RE. Analysis of the effect of liposome encapsulation on vesicant properties, acute and cardiac toxicities, and antitumor efficacy of doxorubicin. Cancer Chemother. Pharmacol. 1989;23:81-86.
7. Fan D, Bucana CD, O'Brian CA, Zwelling LA, Seid C, Fidler IJJ. Enhancement of murine tumor cell sensitivity to adriamycin by presentation of the drug in the phosphatidylcholine-phosphatidylserine liposomes, Cancer Res. 1990;50:3619-3626.
8. Mayhew EG, Lasic D, Babbar S, Martin FJ. Pharmacokinetics and antitumor activity of epirubicin encapsulated in long-circulating liposomes incorporating a polyehtylene glycol-derivatized phospholipid. Int. J. Cancer 1992;51:302-309.
9. Hwang SK, Lee KD, Hong K, Friend DS, Papahadjopoulos D. Microscopic localization of sterically stabilized liposomes in colon carcinoma-bearing mice. Cancer Res. 1992;52:5135-5143.
10. Liu D, Mori A, Huang L. Role of the liposome size and RES blockade in controlling biodistribution and tumor uptake of GM1-containing liposomes. Biochim. Biophys. Acta 1992;1104:95-101.
11. Mayer DL, Bally MB, Cullis PR. Strategies for optimizing liposomal doxorubicin. J. Liposome Res 1990;1:463-480.
12. Haran G, Cohen R, Bar LK, Barenholz Y. Transmembrane ammonium sulfate gradients in liposomes produce efficient and stable entrapment of amphipathic weak bases. Biochim. Biophys. Acta 1993;1115:201-215.
13. Rouser G, Fluscher S, Yamamoto A. Two dimensional thin layer chromatographic separation of polar lipids and determination of phopholipids by phosphorus analysis of spots. Lipids 1970;5:494-496.
14. Storm G, Bloois L, Brouwer M, Crommelin DJA. The interaction of cytostatic drugs with adsorbents in aqueous media. The potential implications for liposome preparation. Biochim. Biophys. Acta, 1985;818:343-351.
15. Nir S, Wilschut J, Bentz J. The rate of fusion of phospholipid vesicles and the role of bilayer curvature. Biochim. Biophys. Acta 1982;688:275-278.
16. Boni LT, Hah JS, Hui SW, Mukherjee P, Ho JT, Jung CY. Aggregation and fusion of unilamellar vesicles by poly(ethyleneglycol). Biochim. Biophys. Acta 1984;775:409-418.
17. Eklund KK, Takkunen JE, Kinnunen PKJ. Cation-induced aggregation of acidic phopholipid vesicles: the role of fatty acid unsaturation and cholesterol. Chem. Phys. Lipids 1991;57:59-66.
18. Leung SO, Ho JT. Effect of membrane phase transition on long-time calcium-induced fusion of phophatidylserine vesicles. Chem. Phys. Lipids 1991;57:103-107.
19. Tomita T, Watanabe M, Takahashi T, Kumai K, Tadakuma T, Yasuda T. Temperature-sensitive liposomes release of adryamicin, an amphipilic antitumor agent, from dipalmitoylphosphatidylcholine-cholesterol liposomes. Biochim. Biophys. Acta 1989;978:185-190.
20. Wolf FA, Maliepaard M, Dorsten F, Berghuis I, Nicolay K, Kruijff B. Comparable interaction of doxorubicin with various acidic phopholipids results in changes of lipid order and dynamics. Biochim. Biophys. Acta 1991; 1096:67-80.
21. Goormaghtigh E, Chatelain P, Caspers J, Ruysschaert JM. Evidence of specific complex between adriamycin and negatively charged phospholipids. Biochim. Biophys. Acta 1980;597:1-14.
22. Nicolay K, Neut R, Fok JJ, Kruijff B. Effects of adryamicin on lipid polymorphism in cardiolipin-containing model and mitochondrial membranes. Biochim. Biophys. Acta 1985;819:55-65.